240 related articles for article (PubMed ID: 19159248)
21. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
22. SiRNA delivery systems based on neutral cross-linked dendrimers.
Liu J; Zhou J; Luo Y
Bioconjug Chem; 2012 Feb; 23(2):174-83. PubMed ID: 22292572
[TBL] [Abstract][Full Text] [Related]
23. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
24. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
26. PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.
Liu XX; Rocchi P; Qu FQ; Zheng SQ; Liang ZC; Gleave M; Iovanna J; Peng L
ChemMedChem; 2009 Aug; 4(8):1302-10. PubMed ID: 19533723
[TBL] [Abstract][Full Text] [Related]
27. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
[TBL] [Abstract][Full Text] [Related]
29. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
[TBL] [Abstract][Full Text] [Related]
30. Synergistic anticancer effects of co-delivery of linc-RoR siRNA and curcumin using polyamidoamine dendrimers against breast cancer.
Vahedi F; Javan B; Sharbatkhari M; Soltani A; Shafiee M; Memarian A; Erfani-Moghadam V
Biochem Biophys Res Commun; 2024 Apr; 705():149729. PubMed ID: 38452515
[TBL] [Abstract][Full Text] [Related]
31. PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.
Waite CL; Roth CM
Bioconjug Chem; 2009 Oct; 20(10):1908-16. PubMed ID: 19775120
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.
Patil ML; Zhang M; Minko T
ACS Nano; 2011 Mar; 5(3):1877-87. PubMed ID: 21322531
[TBL] [Abstract][Full Text] [Related]
33. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
[TBL] [Abstract][Full Text] [Related]
35. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
36. Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.
Amreddy N; Ahmed RA; Munshi A; Ramesh R
Methods Mol Biol; 2020; 2059():167-189. PubMed ID: 31435921
[TBL] [Abstract][Full Text] [Related]
37. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.
Pan J; Mendes LP; Yao M; Filipczak N; Garai S; Thakur GA; Sarisozen C; Torchilin VP
Eur J Pharm Biopharm; 2019 Mar; 136():18-28. PubMed ID: 30633973
[TBL] [Abstract][Full Text] [Related]
38. Efficient siRNA delivery based on PEGylated and partially quaternized polyamine nanogels: enhanced gene silencing activity by the cooperative effect of tertiary and quaternary amino groups in the core.
Tamura A; Oishi M; Nagasaki Y
J Control Release; 2010 Sep; 146(3):378-87. PubMed ID: 20621664
[TBL] [Abstract][Full Text] [Related]
39. Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy.
Xu L; Yang H
Methods Mol Biol; 2019; 1974():393-408. PubMed ID: 31099016
[TBL] [Abstract][Full Text] [Related]
40. Erlotinib-Loaded Dendrimer Nanocomposites as a Targeted Lung Cancer Chemotherapy.
Fatani WK; Aleanizy FS; Alqahtani FY; Alanazi MM; Aldossari AA; Shakeel F; Haq N; Abdelhady H; Alkahtani HM; Alsarra IA
Molecules; 2023 May; 28(9):. PubMed ID: 37175381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
